Figure 3
Figure 3. Outcome of CN-AML patients 60 years of age or older with respect to miR-3151 expression and ELN Genetic Group. (A) Disease-free survival. (B) Overall survival.

Outcome of CN-AML patients 60 years of age or older with respect to miR-3151 expression and ELN Genetic Group. (A) Disease-free survival. (B) Overall survival.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal